[Health care of asthma patients in combination therapy with ICS and LABA - An analysis of statutory health insurance data].
The study indicates the patient-centered care of patients with asthma with fixed-dose combination therapy (with three different combinations) regarding the claims-data of several sickness funds. The identified patients were grouped according to their fixed-dose combination, their course of treatment and the number of treatment days with the possibility of two puffs per day. The effects of the corresponding group, their course of treatment and the number of days with two puffs on duration and costs of hospitalisations were evaluated. 47.9 % of the 16 312 insured patients were supplied for only a maximum of 6 out of 24 months with two puffs per day with an ICS/LABA fixed-dose combination. Only 8.3 % received at least two puffs per day for the whole period of investigation. The results may explain the insufficient asthma control found in other studies and serve as basis for further investigations concerning patient centered care. The true reasons for the observed undertreatment remain speculative. The author's recommendations for daily practice are to remain vigilant about activities to measure and manage patient's adherence and their degree of compliance with the medical guidelines.
Institut für Prävention und Gesundheitsförderung an der Universität Duisburg-Essen.
H
H
Friedel
Abteilung für Pneumologie/Interdisziplinäre Internistische Intensivstation Klinik I/Zentrum für Innere Medizin, Universitätsklinikum Rostock.
J C
JC
Virchow
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000191:economics*; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000191:economics; D001249:Asthma / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology; D004338:Drug Combinations; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics*; D015995:Prevalence; D012189:Retrospective Studies
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D004338:Drug Combinations